Operaciones DexCom, Inc. - DXCM CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.24 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.030779% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.013666% | ||||||||
Horario tarifa nocturna | 22:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Dexcom Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Cierre previo* | 107.9 |
Abrir* | 106.59 |
Cambio de 1 año* | -75.52% |
Rango del día* | 106.32 - 109.68 |
Rango de 52 semanas | 66.89-134.77 |
Volumen medio (10 días) | 2.44M |
Volumen medio (3 meses) | 51.68M |
Capitalización de mercado | 41.73B |
Ratio P/E | 201.79 |
Acciones en circulación | 386.26M |
Ingresos | 2.79B |
EPS | 0.54 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.09 |
Próxima fecha de resultados | Feb 9, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 108.28 | 2.05 | 1.93% | 106.23 | 109.84 | 105.23 |
Feb 2, 2023 | 107.90 | 0.32 | 0.30% | 107.58 | 110.31 | 106.42 |
Feb 1, 2023 | 107.51 | 0.41 | 0.38% | 107.10 | 108.48 | 103.89 |
Jan 31, 2023 | 106.93 | 1.92 | 1.83% | 105.01 | 107.47 | 104.88 |
Jan 30, 2023 | 105.41 | 0.30 | 0.29% | 105.11 | 106.79 | 104.90 |
Jan 27, 2023 | 106.60 | 1.74 | 1.66% | 104.86 | 107.65 | 104.40 |
Jan 26, 2023 | 106.51 | 1.61 | 1.53% | 104.90 | 106.94 | 103.66 |
Jan 25, 2023 | 103.92 | 0.84 | 0.81% | 103.08 | 104.87 | 102.36 |
Jan 24, 2023 | 105.89 | 0.74 | 0.70% | 105.15 | 106.36 | 102.52 |
Jan 23, 2023 | 106.25 | -0.75 | -0.70% | 107.00 | 108.73 | 105.87 |
Jan 20, 2023 | 107.72 | 1.88 | 1.78% | 105.84 | 107.91 | 104.65 |
Jan 19, 2023 | 106.01 | 0.12 | 0.11% | 105.89 | 107.57 | 105.56 |
Jan 18, 2023 | 106.54 | -2.35 | -2.16% | 108.89 | 110.13 | 106.33 |
Jan 17, 2023 | 109.39 | 2.37 | 2.21% | 107.02 | 109.54 | 105.38 |
Jan 13, 2023 | 108.28 | 2.72 | 2.58% | 105.56 | 108.52 | 104.94 |
Jan 12, 2023 | 107.03 | 1.74 | 1.65% | 105.29 | 108.38 | 103.20 |
Jan 11, 2023 | 106.04 | -5.64 | -5.05% | 111.68 | 112.32 | 104.94 |
Jan 10, 2023 | 110.78 | 2.23 | 2.05% | 108.55 | 111.86 | 107.67 |
Jan 9, 2023 | 109.89 | -1.90 | -1.70% | 111.79 | 113.12 | 107.21 |
Jan 6, 2023 | 115.67 | 3.49 | 3.11% | 112.18 | 116.86 | 110.41 |
DexCom, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos totales | 573.3 | 718.5 | 1031.6 | 1476 | 1926.7 | 2448.5 |
Ingresos | 573.3 | 718.5 | 1031.6 | 1476 | 1926.7 | 2448.5 |
Coste de los ingresos, total | 194.9 | 226.4 | 367.7 | 530.4 | 622.2 | 739.9 |
Beneficio bruto | 378.4 | 492.1 | 663.9 | 945.6 | 1304.5 | 1708.6 |
Gastos totales de explotación | 637.2 | 761 | 1217.9 | 1333.7 | 1633.1 | 2184.2 |
Gastos de venta/general/administración Gastos, total | 286.2 | 349.2 | 432.8 | 515.7 | 620.7 | 810.5 |
Investigación y desarrollo | 156.1 | 185.4 | 417.4 | 273.5 | 359.9 | 604.2 |
Ingresos de explotación | -63.9 | -42.5 | -186.3 | 142.3 | 293.6 | 264.3 |
Ingresos por intereses (gastos), netos No operativos | -0.3 | -9.5 | 59.8 | -38.1 | -68.6 | -90.4 |
Otros, netos | -0.7 | 3.4 | ||||
Ingresos netos antes de impuestos | -64.9 | -48.6 | -126.5 | 104.2 | 225 | 173.9 |
Ingresos netos después de impuestos | -65.6 | 55.5 | -127.5 | 101.1 | 493.6 | 154.7 |
Beneficio neto antes de partidas extra. Elementos | -65.6 | 55.5 | -127.5 | 101.1 | 493.6 | 154.7 |
Ingresos netos | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -65.6 | 55.5 | -127.5 | 101.1 | 493.6 | 154.7 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Beneficio neto diluido | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Promedio ponderado de acciones diluidas | 334.4 | 345.2 | 352.8 | 369.2 | 390 | 400.4 |
BPA diluido sin partidas extraordinarias | -0.19617 | 0.16078 | -0.36139 | 0.27384 | 1.26564 | 0.38636 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
BPA normalizado diluido | -0.19617 | 0.18149 | -0.35145 | 0.33848 | 1.33881 | 0.50656 |
Total de partidas extraordinarias | -105.7 | 0.4 | 0 | |||
Gastos (ingresos) extraordinarios | 14.1 | 30.3 | 29.6 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Ingresos totales | 505 | 595.1 | 650.2 | 698.2 | 628.8 |
Ingresos | 505 | 595.1 | 650.2 | 698.2 | 628.8 |
Coste de los ingresos, total | 161.1 | 178 | 203.3 | 197.5 | 230.7 |
Beneficio bruto | 343.9 | 417.1 | 446.9 | 500.7 | 398.1 |
Gastos totales de explotación | 459.1 | 494.1 | 532.7 | 698.3 | 587.5 |
Gastos de venta/general/administración Gastos, total | 188.6 | 187 | 199.8 | 235.1 | 220.9 |
Investigación y desarrollo | 109.4 | 129.1 | 128.8 | 236.9 | 135.9 |
Ingresos de explotación | 45.9 | 101 | 117.5 | -0.1 | 41.3 |
Ingresos por intereses (gastos), netos No operativos | -4.6 | -24.3 | -26.8 | -14.6 | -5.2 |
Ingresos netos antes de impuestos | 41.3 | 76.7 | 90.7 | -14.7 | 36.1 |
Ingresos netos después de impuestos | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Beneficio neto antes de partidas extra. Elementos | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Ingresos netos | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Beneficio neto diluido | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Promedio ponderado de acciones diluidas | 418.4 | 398.4 | 402 | 388 | 428.8 |
BPA diluido sin partidas extraordinarias | 0.13504 | 0.15788 | 0.17637 | -0.05 | 0.22691 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | 0.13504 | 0.15788 | 0.17792 | -0.00175 | 0.22691 |
Gastos (ingresos) extraordinarios | 0 | 0.8 | 28.8 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Activo Corriente | 280 | 744.7 | 1699.5 | 1969.4 | 3424.8 | 3684.4 |
Efectivo e inversiones a corto plazo | 123.7 | 548.6 | 1385.6 | 1533.3 | 2707.7 | 2731.2 |
Efectivo y Equivalentes | 94.5 | 441.5 | 1137 | 446.2 | 817.6 | 1052.6 |
Inversiones a corto plazo | 29.2 | 107.1 | 248.6 | 1087.1 | 1890.1 | 1678.6 |
Total deudores, neto | 101.7 | 134.3 | 226.7 | 286.3 | 428.5 | 514.3 |
Accounts Receivable - Trade, Net | 101.7 | 134.3 | 226.7 | 286.3 | 428.5 | 514.3 |
Total Inventory | 45.4 | 45.2 | 70.7 | 119.8 | 234.7 | 357.3 |
Prepaid Expenses | 9.2 | 16.6 | 16.5 | 30 | 53.9 | 81.6 |
Total Assets | 402.8 | 904.1 | 1916 | 2395 | 4290.5 | 4933.3 |
Property/Plant/Equipment, Total - Net | 109.4 | 145.6 | 183.1 | 392.8 | 608.6 | 889.9 |
Property/Plant/Equipment, Total - Gross | 156.6 | 200.4 | 262.9 | 497.8 | 762.8 | 1121.4 |
Accumulated Depreciation, Total | -47.2 | -54.8 | -79.8 | -105 | -154.2 | -231.5 |
Goodwill, Net | 11.3 | 12.1 | 18.7 | 18.6 | 19.3 | 26.5 |
Intangibles, Net | 0.2 | 31.5 | ||||
Other Long Term Assets, Total | 1.9 | 1.7 | 14.7 | 14.2 | 237.8 | 301 |
Total Current Liabilities | 102.4 | 138.9 | 222.4 | 360.2 | 614.1 | 720.8 |
Accounts Payable | 24.5 | 46.7 | 75.5 | 102.3 | 163.3 | 189.4 |
Accrued Expenses | 77 | 89 | 144 | 255.6 | 439.8 | 514.3 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.6 | 8.8 | |||
Other Current Liabilities, Total | 0.9 | 3.2 | 2.9 | 1.7 | 2.2 | 17.1 |
Total Liabilities | 119 | 484.7 | 1252.7 | 1512.4 | 2464 | 2891.2 |
Total Long Term Debt | 6 | 334.3 | 1017.6 | 1074.1 | 1721.2 | 2038.8 |
Long Term Debt | 0 | 327.6 | 1010.3 | 1059.7 | 1667.2 | 1981.8 |
Capital Lease Obligations | 6 | 6.7 | 7.3 | 14.4 | 54 | 57 |
Other Liabilities, Total | 10.6 | 11.5 | 12.7 | 78.1 | 128.7 | 125.7 |
Total Equity | 283.8 | 419.4 | 663.3 | 882.6 | 1826.5 | 2042.1 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 905.7 | 1093.7 | 1560.6 | 1675.9 | 2125.3 | 2109 |
Retained Earnings (Accumulated Deficit) | -621 | -671.8 | -798.9 | -695.7 | -202.1 | 138.7 |
Other Equity, Total | -1 | -2.6 | 1.5 | 2.3 | 3.2 | 0.5 |
Total Liabilities & Shareholders’ Equity | 402.8 | 904.1 | 1916 | 2395 | 4290.5 | 4933.3 |
Total Common Shares Outstanding | 338.4 | 348 | 360 | 366.4 | 384.4 | 388 |
Treasury Stock - Common | -100 | -100 | -100 | -206.2 | ||
Deferred Income Tax | 5.9 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 3445.1 | 3474.2 | 3656.2 | 3684.4 | 3746.6 |
Efectivo e inversiones a corto plazo | 2632.6 | 2584.9 | 2697.9 | 2731.2 | 2688.2 |
Efectivo y Equivalentes | 733.8 | 1158.8 | 1444.3 | 1052.6 | 716 |
Inversiones a corto plazo | 1898.8 | 1426.1 | 1253.6 | 1678.6 | 1972.2 |
Total deudores, neto | 443.4 | 483.5 | 529.1 | 514.3 | 544.5 |
Accounts Receivable - Trade, Net | 443.4 | 483.5 | 529.1 | 514.3 | 544.5 |
Total Inventory | 289.7 | 319.3 | 351.3 | 357.3 | 342.2 |
Prepaid Expenses | 79.4 | 86.5 | 77.9 | 81.6 | 171.7 |
Total Assets | 4389.8 | 4503.8 | 4775.9 | 4933.3 | 5057 |
Property/Plant/Equipment, Total - Net | 688.7 | 770.8 | 833.5 | 889.9 | 938.8 |
Property/Plant/Equipment, Total - Gross | 860.7 | 957.6 | 1036.5 | 1121.4 | 1203.7 |
Accumulated Depreciation, Total | -172 | -186.8 | -203 | -231.5 | -264.9 |
Goodwill, Net | 18.9 | 19.1 | 23.9 | 26.5 | 26.6 |
Other Long Term Assets, Total | 237.1 | 239.7 | 238.9 | 301 | 313.6 |
Total Current Liabilities | 604.1 | 600.7 | 734.9 | 720.8 | 711.4 |
Accounts Payable | 152.2 | 165.9 | 210 | 189.4 | 150.1 |
Accrued Expenses | 450 | 433 | 522.6 | 514.3 | 558.6 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 1.9 | 1.8 | 2.3 | 17.1 | 2.7 |
Total Liabilities | 2486.6 | 2506.2 | 2639.8 | 2891.2 | 2867.7 |
Total Long Term Debt | 1743 | 1768.1 | 1761.3 | 2038.8 | 2027.5 |
Long Term Debt | 1688.8 | 1710.7 | 1703.5 | 1981.8 | 1965.9 |
Capital Lease Obligations | 54.2 | 57.4 | 57.8 | 57 | 61.6 |
Other Liabilities, Total | 139.5 | 137.4 | 143.6 | 125.7 | 122.7 |
Total Equity | 1903.2 | 1997.6 | 2136.1 | 2042.1 | 2189.3 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 2162 | 2193.6 | 2322.1 | 2109 | 1996.6 |
Retained Earnings (Accumulated Deficit) | -161.8 | -98.9 | -28 | 138.7 | 236 |
Treasury Stock - Common | -100 | -100 | -159.5 | -206.2 | -37.3 |
Other Equity, Total | 2.9 | 2.8 | 1.4 | 0.5 | -6.1 |
Total Liabilities & Shareholders’ Equity | 4389.8 | 4503.8 | 4775.9 | 4933.3 | 5057 |
Total Common Shares Outstanding | 386.8 | 386.8 | 387.6 | 388 | 392.4 |
Intangibles, Net | 23.4 | 31.5 | 31.4 | ||
Deferred Income Tax | 5.9 | 6.1 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos netos/Línea de salida | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Efectivo de actividades de explotación | 56.2 | 92 | 123.2 | 314.5 | 475.6 | 442.5 |
Efectivo de actividades de explotación | 15 | 16.1 | 29.1 | 48.7 | 67.1 | 102 |
Partidas no monetarias | 113.1 | 123.5 | 262.1 | 158.6 | 213 | 322.7 |
Cash Taxes Paid | 0.1 | 1.4 | 2.3 | 4.8 | 3.6 | 16.8 |
Intereses pagados en efectivo | 0.1 | 2.4 | 3.6 | 10.4 | 10.6 | 11.6 |
Cambios en el capital circulante | -6.3 | 2.6 | -40.9 | 6.1 | -20.8 | -132 |
Efectivo de actividades de inversión | -55.9 | -144.4 | -139.8 | -1015.2 | -1018 | -216.1 |
Gastos de capital | -55.7 | -66 | -67.1 | -180 | -199 | -389.2 |
Otras partidas de flujo de caja de inversión, total | -0.2 | -78.4 | -72.7 | -835.2 | -819 | 173.1 |
Efectivo procedente de actividades de financiación | 8.1 | 399.1 | 710.4 | 10.7 | 912.1 | 10.4 |
Emisión (retiro) de acciones, neto | 10.4 | 10.1 | 94.6 | 11.9 | 15.3 | 20.3 |
Emisión (amortización) de deuda, neta | -2.3 | 389 | 617.7 | 0 | 906.2 | 0 |
Variación neta de la tesorería | 8.4 | 347 | 695.6 | -690.7 | 371.8 | 235.4 |
Efectos del cambio de divisas | 0.3 | 1.8 | -0.7 | 2.1 | -1.4 | |
Elementos de flujo de caja de financiación | -1.9 | -1.2 | -9.4 | -9.9 | ||
Deferred Taxes | -277.3 | -4.9 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 40.3 | 103.2 | 174.1 | 154.7 | 97.3 |
Cash From Operating Activities | 27.8 | 89.4 | 336.7 | 442.5 | 71 |
Cash From Operating Activities | 20.9 | 44.4 | 69.9 | 102 | 36.8 |
Deferred Taxes | -0.3 | 0.1 | 0.2 | -4.9 | 0.1 |
Non-Cash Items | 58.2 | 120.3 | 185.1 | 322.7 | 34.3 |
Changes in Working Capital | -91.3 | -178.6 | -92.6 | -132 | -97.5 |
Cash From Investing Activities | -112.2 | 251 | 280 | -216.1 | -411.8 |
Capital Expenditures | -99.7 | -200.9 | -309 | -389.2 | -101.6 |
Other Investing Cash Flow Items, Total | -12.5 | 451.9 | 589 | 173.1 | -310.2 |
Cash From Financing Activities | 0.8 | 0.4 | 11.2 | 10.4 | 5.3 |
Financing Cash Flow Items | -7.9 | -8.3 | -9.1 | -9.9 | -4.8 |
Issuance (Retirement) of Stock, Net | 8.7 | 8.7 | 20.3 | 20.3 | 10.1 |
Foreign Exchange Effects | -0.4 | 0.1 | -0.9 | -1.4 | -1 |
Net Change in Cash | -84 | 340.9 | 627 | 235.4 | -336.5 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.263 | 43504103 | 506655 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.6274 | 21736347 | -75610 | 2022-09-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 4.4796 | 17302885 | -802293 | 2022-12-31 | LOW |
Sands Capital Management, LLC | Investment Advisor | 4.3218 | 16693318 | -1208895 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2437 | 16391712 | 156880 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 2.7262 | 10530238 | 2847171 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.5609 | 9891601 | -119599 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.3422 | 9047009 | 3297715 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0751 | 8015184 | 192962 | 2022-09-30 | LOW |
Nuveen LLC | Pension Fund | 2.0577 | 7948042 | 209503 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.8817 | 7268168 | -646636 | 2022-09-30 | LOW |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.7976 | 6943376 | -1620235 | 2022-09-30 | LOW |
ClearBridge Investments, LLC | Investment Advisor/Hedge Fund | 1.4004 | 5408974 | -298536 | 2022-09-30 | LOW |
Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.334 | 5152750 | -589239 | 2022-12-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 1.265 | 4886021 | -1210023 | 2022-09-30 | LOW |
William Blair & Company, L.L.C. (Research) | Research Firm | 1.1965 | 4621748 | 119780 | 2022-09-30 | LOW |
Voya Investment Management LLC | Investment Advisor/Hedge Fund | 1.1531 | 4454124 | 1510296 | 2022-09-30 | MED |
Capital World Investors | Investment Advisor | 0.9751 | 3766229 | 47344 | 2022-09-30 | LOW |
Macquarie Investment Management | Investment Advisor | 0.9446 | 3648714 | 374085 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.8992 | 3473151 | -620387 | 2022-09-30 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com GroupTraders
Clientes activos mensualmente
Volumen mensual de inversión
Retiros por mes
Calculadora de trading
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
DexCom Company profile
Sobre DexCom, Inc.
Dexcom, Inc. (Dexcom) es una compañía de dispositivos médicos. La compañía se enfoca en el diseño, desarrollo y comercialización de sistemas de monitoreo continuo de glucosa (MCG) para uso ambulatorio por personas con diabetes y para uso de proveedores de servicios de salud. Los productos de la compañía consisten en DexCom G4 PLATINUM y DexCom G5 Mobile. La Compañía está comercializando su sistema CGM de quinta generación. La Compañía comercializa DexCom G4 PLATINUM bajo la marca "Conformite Europeenne" (Marca CE), en la Unión Europea, Australia, Nueva Zelanda y los países de Asia y América Latina, y en los Estados Unidos con la aprobación de la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA por sus siglas en inglés). El sistema de monitoreo remoto DexCom G4 PLATINUM con "Share" utiliza una conexión inalámbrica entre el receptor de un paciente y una aplicación en el iPhone, iPod touch o iPad del paciente para transmitir información de glucosa a las aplicaciones en los dispositivos móviles de destinatarios designados.
- IndustriaMedical Equipment / Supplies / Distribution
- Dirección6340 Sequence Dr, SAN DIEGO, CA, United States (USA)
- Empleados6300
- CEOKevin Sayer
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
6340 Sequence Dr
SAN DIEGO
CALIFORNIA 92121
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 485.000 traders de todo el mundo que eligen operar con Capital.com